Abstract:Use of archival resources has been limited to date by inconsistent methods for genomic profiling of degraded RNA from formalin-fixed paraffin-embedded (FFPE) samples. RNA-sequencing offers a promising way to address this problem. Here, we evaluated transcriptomic dose responses using RNA-sequencing in paired FFPE and frozen (FROZ) samples from 2 archival studies in mice, one <2 years old and the other >20 years old. Experimental treatments included 3 different doses of di(2-ethylhexyl)phthalate or dichloroacet… Show more
“…Finally, in our study we used FFPE samples: this treatment is known to produce bias, as we directly observe in some of our libraries and probably affecting low expressed genes due to high rate of RNA degradation. However, studies have been conducted 76 proving that results on FFPE samples correlated with the one obtained with fresh tissue with some caveats.…”
Interactions between tumor cells and tumor microenvironment are considered critical in carcinogenesis, tumor invasion and metastasis. To examine transcriptome changes and to explore the relationship with tumor microenvironment in canine cutaneous melanocytoma and melanoma, we extracted RNA from formalin-fixed, paraffin-embedded (FFPE) specimens and analyzed them by means of RNA-seq for transcriptional analysis. Melanocytoma and melanoma samples were compared to detect differential gene expressions and significant enriched pathways were explored to reveal functional relations between differentially expressed genes. The study demonstrated a differential expression of 60 genes in melanomas compared to melanocytomas. The differentially expressed genes cluster in the extracellular matrix-receptor interaction, protein digestion and absorption, focal adhesion and PI3K-Akt (phosphoinositide 3-kinase/protein kinase B) signaling pathways. Genes encoding for several collagen proteins were more commonly differentially expressed. Results of the RNA-seq were validated by qRT-PCR and protein expression of some target molecules was investigated by means of immunohistochemistry. We hypothesize that the developing melanoma actively promotes collagen metabolism and extracellular matrix remodeling as well as enhancing cell proliferation and survival contributing to disease progression and metastasis. In this study, we also detected unidentified genes in human melanoma expression studies and uncover new candidate drug targets for further testing in canine melanoma.
“…Finally, in our study we used FFPE samples: this treatment is known to produce bias, as we directly observe in some of our libraries and probably affecting low expressed genes due to high rate of RNA degradation. However, studies have been conducted 76 proving that results on FFPE samples correlated with the one obtained with fresh tissue with some caveats.…”
Interactions between tumor cells and tumor microenvironment are considered critical in carcinogenesis, tumor invasion and metastasis. To examine transcriptome changes and to explore the relationship with tumor microenvironment in canine cutaneous melanocytoma and melanoma, we extracted RNA from formalin-fixed, paraffin-embedded (FFPE) specimens and analyzed them by means of RNA-seq for transcriptional analysis. Melanocytoma and melanoma samples were compared to detect differential gene expressions and significant enriched pathways were explored to reveal functional relations between differentially expressed genes. The study demonstrated a differential expression of 60 genes in melanomas compared to melanocytomas. The differentially expressed genes cluster in the extracellular matrix-receptor interaction, protein digestion and absorption, focal adhesion and PI3K-Akt (phosphoinositide 3-kinase/protein kinase B) signaling pathways. Genes encoding for several collagen proteins were more commonly differentially expressed. Results of the RNA-seq were validated by qRT-PCR and protein expression of some target molecules was investigated by means of immunohistochemistry. We hypothesize that the developing melanoma actively promotes collagen metabolism and extracellular matrix remodeling as well as enhancing cell proliferation and survival contributing to disease progression and metastasis. In this study, we also detected unidentified genes in human melanoma expression studies and uncover new candidate drug targets for further testing in canine melanoma.
“…All of the samples were formalin-fixed, paraffin-embedded tissue samples from either the Small Animal Hospital of Zurich or external cases sent in by veterinarians practising in Switzerland. Cases were selected with the help of a board-certified veterinary pathologist (A.M.) using the following criteria; female dogs, simple mammary carcinomas, appropriate tumour stroma content, FFPE samples not older than two years [58], areas with no obvious or only negligible inflammation, and samples were paraffin-embedded on their arrival day at the Pathology, (i.e., no prolonged storage in formalin). During our initial screening for suitable cases, those which contained only highly inflamed stroma were excluded.…”
Cancer-associated stroma (CAS) plays a key role in cancer initiation and progression. Spontaneously occurring canine mammary carcinomas are viewed as excellent models of human breast carcinomas. Considering the importance of CAS for human cancer, it likely plays a central role in canine tumours as well. So far, however, canine CAS lacks characterisation, and it remains unclear whether the biology between CAS from canine and human tumours is comparable. In this proof-of-principle study, using laser-capture microdissection, we isolated CAS and normal stroma from 13 formalin-fixed paraffin embedded canine simple mammary carcinomas and analysed the expression of seven known human CAS markers by RT-qPCR (Reverse Transcription quantitative PCR) and validated some targets by immunohistochemistry. We found that Col1a1 (Collagen1α1), αSMA (alpha Smooth Muscle Actin), FAP (Fibroblast activation protein), PDGFRβ (Platelet-derived growth factor receptor beta), and Caveolin-1 were significantly upregulated in canine CAS, and the expression of CXCL12 (Stromal cell derived factor 1) significantly decreased, whereas MMP2 (Matrix Metalloproteinase 1) and IL6 (Interleukin 6) did not change. Our results suggest strong similarities in CAS biology in canine and human mammary carcinomas but also reveal some differences. To the best of our knowledge, this is the first report to provide a comprehensive expression analysis of the most important CAS markers in canine simple mammary carcinomas and further supports the validity of the dog as model for human cancer.
“…Capturing and sequencing intronic DNA to identify gene fusions may be problematic because genomic breakpoints are broadly distributed within corresponding introns that frequently contain multiple repeat sequences . Although NGS analysis of transcriptomes (RNA‐seq) is an alternative approach, RNA‐seq using FFPE samples is challenging because the RNA recovered from FFPE is severely fragmented and modified . Although other approaches such as the cDNA capture method or anchored multiplex PCR‐based method were recently reported to be successful methods for RNA‐seq with FFPE samples, large‐scale validation for their clinical use is required.…”
Section: Introductionmentioning
confidence: 99%
“…[20][21][22] Although NGS analysis of transcriptomes (RNAseq) is an alternative approach, RNA-seq using FFPE samples is challenging because the RNA recovered from FFPE is severely fragmented and modified. [23][24][25][26] Although other approaches such as the cDNA capture method 27 or anchored multiplex PCR-based method 28 were recently reported to be successful methods for RNA-seq with FFPE samples, large-scale validation for their clinical use is required.…”
Tumor molecular profiling is becoming a standard of care for patients with cancer, but the optimal platform for cancer sequencing remains undetermined. We established a comprehensive assay, the Todai OncoPanel (
TOP
), which consists of
DNA
and
RNA
hybridization capture‐based next‐generation sequencing panels. A novel method for target enrichment, named the junction capture method, was developed for the
RNA
panel to accurately and cost‐effectively detect 365 fusion genes as well as aberrantly spliced transcripts. The
TOP RNA
panel can also measure the expression profiles of an additional 109 genes. The
TOP DNA
panel was developed to detect single nucleotide variants and insertions/deletions for 464 genes, to calculate tumor mutation burden and microsatellite instability status, and to infer chromosomal copy number. Clinically relevant somatic mutations were identified in 32.2% (59/183) of patients by prospective
TOP
testing, signifying the clinical utility of
TOP
for providing personalized medicine to cancer patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.